IFP Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

IFP Advisors’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-346	Closed	-$15.5K	–	4689
2024 Q3	$15.5K	Sell	346 -418	-55%	-$17.7K	﹤0.01%	2248
2024 Q2	$31.2K	Hold	764	–	–	﹤0.01%	1879
2024 Q1	$32.3K	Buy	+764	New	+$32.1K	﹤0.01%	1756

IFP Advisors's CERE Position: Q4 2024 in Review

IFP Advisors sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q4 2024, closing a stake of 346 shares — an estimated $15.5K sold.

IFP Advisors first reported a position in CERE in Q1 2024 and held it in 3 quarters. The position peaked at $32.3K in Q1 2024. 0 funds tracked by Wall St. Rank hold CERE as of Q4 2024.

IFP Advisors reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
IFP Advisors sold 346 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q4 2024, an estimated $15.5K.
IFP Advisors first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
IFP Advisors's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $32.3K in Q1 2024.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q4 2024.

Based on IFP Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.